Qube Research & Technologies (QRT)’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-118,808
Closed -$304K 3120
2025
Q1
$304K Buy
118,808
+93,941
+378% +$240K ﹤0.01% 2097
2024
Q4
$46.8K Sell
24,867
-11,571
-32% -$21.8K ﹤0.01% 2381
2024
Q3
$37.2K Sell
36,438
-84,592
-70% -$86.3K ﹤0.01% 2396
2024
Q2
$142K Buy
+121,030
New +$142K ﹤0.01% 2172